Heritage Wealth Management LLC increased its position in shares of Natus Medical Incorporated (NASDAQ:NTUS) by 43.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,114 shares of the company’s stock after acquiring an additional 944 shares during the quarter. Heritage Wealth Management LLC’s holdings in Natus Medical were worth $78,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently made changes to their positions in the company. Royal Bank of Canada increased its stake in shares of Natus Medical by 612.8% during the second quarter. Royal Bank of Canada now owns 2,851 shares of the company’s stock worth $74,000 after buying an additional 2,451 shares during the period. Advisor Group Holdings Inc. boosted its holdings in shares of Natus Medical by 1,193.3% in the second quarter. Advisor Group Holdings Inc. now owns 2,897 shares of the company’s stock valued at $75,000 after acquiring an additional 2,673 shares during the period. US Bancorp DE acquired a new stake in shares of Natus Medical in the second quarter valued at approximately $80,000. SG Americas Securities LLC acquired a new stake in shares of Natus Medical in the third quarter valued at approximately $125,000. Finally, Liberty Wealth Management LLC acquired a new stake in shares of Natus Medical in the second quarter valued at approximately $191,000. 91.78% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NTUS stock opened at $23.94 on Friday. Natus Medical Incorporated has a fifty-two week low of $21.87 and a fifty-two week high of $29.70. The stock has a market cap of $817.55 million, a P/E ratio of 49.88 and a beta of 0.55. The business has a fifty day simple moving average of $24.28 and a 200-day simple moving average of $25.20.
In other news, insider Dong Chune Christopher Chung sold 11,787 shares of Natus Medical stock in a transaction dated Thursday, December 9th. The stock was sold at an average price of $23.08, for a total value of $272,043.96. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 2.00% of the company’s stock.
Separately, Zacks Investment Research raised Natus Medical from a “sell” rating to a “hold” rating in a report on Thursday, January 6th.
About Natus Medical
Natus Medical, Inc provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Read More: What are economic reports?
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.